Cancer/testis antigen 2 (103-111)

Cancer/testis antigen 2 (103-111) is a synthetic peptide fragment corresponding to amino acid residues 103 through 111 of the cancer/testis antigen 2 (CTAG2) protein. As a member of the cancer/testis antigen family, CTAG2 is characterized by its restricted expression pattern, predominantly found in various tumor types and in testicular germ cells, but generally absent from normal somatic tissues. The 103-111 peptide sequence is of particular interest due to its role as a defined epitope, enabling the study of antigen-specific immune responses and facilitating investigations into tumor immunology, antigen presentation, and T cell recognition. Its defined sequence and immunological relevance make it a valuable research tool for exploring mechanisms of tumor-associated antigenicity and immune targeting.

Epitope mapping: The 103-111 peptide fragment is widely employed in epitope mapping studies to delineate the precise regions of CTAG2 recognized by cytotoxic T lymphocytes (CTLs) and other antigen-specific immune cells. By presenting this defined sequence to immune effector cells, researchers can identify immunodominant epitopes, characterize T cell receptor specificity, and assess the immunogenic potential of CTAG2 in various experimental systems. Such studies contribute to a deeper understanding of tumor antigenicity and the molecular determinants of immune recognition.

Antigen presentation research: The peptide serves as a model substrate for investigating major histocompatibility complex (MHC) class I antigen processing and presentation pathways. Incorporation of the 103-111 sequence into in vitro assays allows for the evaluation of peptide binding affinities to MHC molecules, assessment of peptide stability, and quantification of surface expression on antigen-presenting cells. These applications provide critical insights into the efficiency and selectivity of antigen presentation, informing the design of immunological assays and the development of antigen-specific reagents.

T cell functional assays: Cancer/testis antigen 2 (103-111) is frequently utilized in functional assays to stimulate or detect antigen-specific T cell populations. By loading this peptide onto dendritic cells or using it directly in ELISPOT, intracellular cytokine staining, or proliferation assays, scientists can quantify CTAG2-specific T cell responses, measure cytokine release, and investigate the functional status of immune effector cells. These approaches are essential for evaluating immune reactivity in preclinical models and human samples, supporting the development of immunotherapeutic strategies.

Peptide-based vaccine research: The defined nature of the 103-111 epitope makes it a useful component in studies aiming to design and optimize peptide-based vaccines targeting tumor antigens. Researchers can use the peptide in immunogenicity testing, formulation optimization, and adjuvant screening to assess its capacity to induce robust and specific immune responses in vitro and in vivo. Such investigations are instrumental in advancing the field of cancer immunoprevention and immunotherapy research by identifying promising antigenic targets and evaluating their translational potential.

Analytical assay development: The synthetic peptide is also valuable in the development and validation of analytical assays, such as mass spectrometry-based detection methods or peptide-MHC multimer generation. Its well-defined sequence and immunological relevance enable precise calibration of detection systems, standardization of assay conditions, and benchmarking of novel analytical platforms. These applications facilitate reliable quantification of antigen-specific responses and contribute to quality control in immunological research workflows.

1. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients

2. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

3. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

4. Quantitative Analysis of Ligands Effects on Bioefficacy of Nanoemulsion encapsulating Depigmenting Active

5. Extended exenatide administration enhances lipid metabolism and exacerbates pancreatic injury in mice on a high fat, high carbohydrate diet